biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Yo, TT...

<< Previous

Bullboard Posts

Next >>

Post by Boomskidon Aug 21, 2023 11:12pm

130 Views

Post# 35599197

Yo, TT...

Just checking in, bud. Hope you're ok. I get worried when trollers ain't.

So, whatchya doin? Watching old films from your pee wee hockey days?

Looking forward yapping with you in a few days or weeks.

Stay cool, man.

jd

PS. You should be pleased, maybe honoured. I usually just respond to posts. I don't often start any personal contacts with anybody. I'm shy, maybe. G'nite.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024